Miller Andrew Craig 4
4 · Kyverna Therapeutics, Inc. · Filed Mar 4, 2026
Insider Transaction Report
Form 4
Miller Andrew Craig
Director
Transactions
- Award
Common Stock
[F1]2026-02-24+11,006→ 11,006 total - Award
Stock Option (right to buy)
[F2]2026-02-24+42,945→ 42,945 totalExercise: $7.95Exp: 2036-02-24→ Common Stock (42,945 underlying)
Footnotes (2)
- [F1]Represents a restricted stock unit award of common stock and 1/3rd of the shares underlying the restricted stock unit award shall vest on each one-year anniversary of the date of grant, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
- [F2]1/36th of the shares subject to the option shall vest on each monthly anniversary of the date of grant, subject to the Reporting Person's continuous service to the Issuer on and through each applicable vesting date, inclusive.
Signature
/s/ Marc Grasso, as Attorney-in-Fact|2026-03-04